This is a crucial step in order to make gene therapy more effective and to increase the number of patients able to access it.

IVIg is administered in a standard dose of 2 g/kg divided over 3-5 days; however, despite this therapy, some patients ... treated with 2 g/kg of IVIg. Total IgG levels were determined in serum ...

In the study, the firm will enroll previously treated patients whose tumors are positive for FRα based on IHC testing.

As we move past a worldwide pandemic, therapy has become standardized to some extent. The only thing that hasn’t changed much is the cost. Though cheaper than in-person therapy, online therapy ...

Some people have difficulty leaving home to go to physical therapy. For these individuals, a physical therapist may come to their home to work with them to restore normal functional mobility. Check ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series in ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that it has commenced a Phase Ib study evaluating MOv18 IgE in patients with ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosisFurther development of namilumab for the treatment of ...

Multiplexed assays of variant effect are an increasingly important tool in genetic research and including more context specificity in their design would aid interpretation and discovery.